Please login to the form below
Green Valley
This page shows the latest Green Valley news and features for those working in and with pharma, biotech and healthcare.
Green Valley’s algae-based Alzheimer’s drug to undergo global clinical trials
Gained conditional approval in China in November. To the surprise of the global Alzheimer’s research community, China approved Shanghai Green Valley Pharmaceuticals' algae-based Alzheimer’s treatment GV-971 last ... It seems that Green Valley
Latest news
-
China okays Green Valley’s algae-based drug for Alzheimer’s drug
China’s regulatory agency has granted a conditional approval to an Alzheimer’s drug from Shanghai Green Valley Pharmaceuticals that is due to start phase 3 trials in the US and ... Green Valley says it will launch Oligomannate in China 'very soon'
More from news
Approximately 2 fully matching, plus 0 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- New study identifies drugs that are safe to use in COVID-19 treatment
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
- Pfizer’s ALK inhibitor Lorbrena hits the mark in head-to-head lung cancer trial
- BMS eyes approval for second Opdivo combo in kidney cancer
- FDA hands BMS and bluebird bio a priority review for ide-cel
- 20 for 2020 – Five pharma companies to watch
PMHub
Health Unlimited
Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...
Latest intelligence
- Surviving cancer: a new era for patients
- Now more than ever, a shift in perspective is needed...
- Crisis? No problem!
- Issues planning & management for pharma spokespeople, by Andrew Smith...
- Are patient recruitment and retention rates rising or falling?
- First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Quick links
Infographics
